Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × Neck Dissection × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Tongue Neoplasms 1 Thyroid Neoplasms 1 Pain, Postoperative 1 Mouth Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Iodine-131 13 lenvatinib 11 Magnetic Resonance Spectroscopy 10 trametinib 9 vandetanib 8 pembrolizumab 8 Sorafenib 8 dabrafenib 7 Thyroxine 7 Thyrotropin Alfa 7 Paclitaxel 7 selpercatinib 6 Surgical Procedures, Operative 6 Sunitinib 6 pazopanib 5 cabozantinib 5 Saline Solution 5 Everolimus 5 anlotinib 4 Vemurafenib 4 Triiodothyronine 4 Thyroidectomy 4 Radiofrequency Ablation 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Dexmedetomidine 4 Cyclophosphamide 4 fosbretabulin 3 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡